Waltham, MA-based fluorescence-guided imaging technology company Lumicell has named Marnie Curbow as CEO, effective immediately.
Curbow joined the company in October 2025 as vice president of sales. She was later promoted to chief commercial officer, overseeing sales, marketing, reimbursement, and clinical applications. Before Lumicell, she was general manager and vice president of sales diagnostics for the Americas at Rhinomed, according to the vendor.
Lumicell’s Lumisight (pegulicianine) optical imaging agent received approval from the U.S. Food and Drug Administration (FDA) in April 2024 and is designed to help surgeons identify residual cancer during lumpectomy. Under Curbow, the company plans to expand adoption of the technology and pursue additional solid tumor indications, Lumicell said.
